Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2006

Study Completion Date

February 29, 2008

Conditions
Breast CancerNon Small Cell Lung CancerProstate Cancer
Interventions
DRUG

vinorelbine oral formulation

Patients will take three times a week \[Monday, Wednesday and Friday\] by mouth, a standard dose of soft capsules of vinorelbine given at dose ascribed by randomization procedure

Trial Locations (11)

11526

Henry Dunant Hospital, Athens

Sotiria Hospital, Athens

13122

Agii Anargiri Cancer Hospital, Athens

15123

Hygeia Hospital, Athens

18547

Metropolitan Hospital, Athens

45500

University General Hospital of Ioannina, Medical Oncology Dept, Ioannina

54007

"Theagenio Hospital", Thessaloniki

73300

General Hospital of Chania, Chania

124 62

"University Hospital Attikon", Athens

265 00

University Hospital of Patras, Pátrai

564 03

"Papageorgiou Cancer Hospital", Thessaloniki

All Listed Sponsors
collaborator

University of Ioannina

OTHER

lead

Hellenic Cooperative Oncology Group

OTHER

NCT00278070 - Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | Biotech Hunter | Biotech Hunter